In the article, “Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma”,[1] which appears in Volume 98, Issue 2 of Medicine, Figure 1 has been replaced with the below figure. Here, ERBB2 is linked to invasive ductal breast carcinoma.